NeuroPace Inc (NPCE)
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
NeuroPace, Inc.
NASDAQ:NPCEHealthcare · Medical - Devices
-5.46%$12.30
AH$12.30+0.00%vs close
Mkt Cap$422.19M
Float24.06M
O/S34.32M
Vol
$ Vol
RVOL
Inst Own77.4%
SI3.7%
Earnings
Dilution
Financials Summary
Revenue$99.99M
Net Income-$21.46M
Total Assets$105.56M
Free Cash Flow-$11.34M
Debt & Equity
Debt 79%
Equity 21%
Total Debt$70.84M
Total Equity$19.03M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in NPCE's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$105.56M
Liabilities$86.53M
Accounts Receivable$14.68M
Accounts Payable$2.22M
Inventory$16.9M
PP&E (Net)$11.26M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $99.99M | $79.91M | $65.42M | $45.52M | $45.18M | $41.14M | $36.97M |
| YoY Growth | 25.1% | 22.1% | 43.7% | 0.7% | 9.8% | 11.3% | - |
| Cost of Revenue | $22.77M | $20.82M | $17.3M | $13.03M | $11.75M | $10.87M | $10.51M |
| Gross Profit | $77.22M | $59.09M | $48.12M | $32.49M | $33.44M | $30.27M | $26.46M |
| Gross Margin | 77.2% | 73.9% | 73.6% | 71.4% | 74.0% | 73.6% | 71.6% |
| Research and Development | $27.89M | $23.65M | $20.78M | $21.95M | $18.21M | $15.7M | $18.29M |
| Selling, General, and Administrative | $65.67M | $57.1M | $54.52M | $51.34M | $38.96M | $27.63M | $30.2M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $93.56M | $80.76M | $75.3M | $73.29M | $57.17M | $43.32M | $48.49M |
| Operating Income (EBIT) | -$16.34M | -$21.67M | -$27.17M | -$40.79M | -$23.74M | -$13.05M | -$22.03M |
| Operating Margin | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% | -31.7% | -59.6% |
| Interest Expense | $7.46M | $8.8M | $8.52M | $7.53M | $7.41M | $11.49M | $9.48M |
| Interest Income | $2.82M | $3.02M | $3.05M | $1.58M | $448K | $41K | $261K |
| Other Income (Expense) | -$5.13M | -$5.47M | -$5.78M | -$6.29M | -$12.34M | -$11.23M | -$7.94M |
| Income Before Tax (EBT) | -$21.46M | -$27.14M | -$32.96M | -$47.08M | -$36.08M | -$24.28M | -$29.97M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$21.46M | -$27.14M | -$32.96M | -$47.08M | -$36.08M | -$24.28M | -$29.97M |
| Net Income Margin | -21.5% | -34.0% | -50.4% | -103.4% | -79.9% | -59.0% | -81.1% |
| Supplementary Data | |||||||
| EPS | -0.66 | -0.93 | -1.27 | -1.91 | -2.17 | -2.17 | -2.70 |
| Diluted EPS | -0.66 | -0.93 | -1.27 | -1.91 | -2.17 | -2.17 | -2.70 |
| Weighted Average OS | 32.72M | 29.13M | 25.85M | 24.59M | 16.61M | 11.10M | 11.10M |
| EBITDA | -$12.06M | -$16.57M | -$22.83M | -$36.57M | -$28.37M | -$12.48M | -$20.07M |
| EBITDA Margin | -12.1% | -20.7% | -34.9% | -80.3% | -62.8% | -30.3% | -54.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $21.69M | $13.43M | $18.06M | $6.61M | $19.19M | $26.39M | $4.12M |
| Short-Term Investments | $39.37M | $39.33M | $48.4M | $70.8M | $96.4M | $11.69M | $969K |
| Cash and Short-Term Investments | $61.06M | $52.76M | $66.45M | $77.41M | $115.58M | $38.08M | $5.09M |
| Accounts Receivable | $14.68M | $12.85M | $12.31M | $7.48M | $7.09M | $8.39M | $6.02M |
| Inventory | $16.9M | $13.38M | $11.21M | $9.71M | $7.82M | $6.91M | $7.9M |
| Other Current Assets | $1.44M | $2.35M | $2.74M | $3.11M | $100K | $0 | $0 |
| Total Current Assets | $94.07M | $81.34M | $92.72M | $97.71M | $132.82M | $54.56M | $20.26M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $11.26M | $12.89M | $14.41M | $15.9M | $603K | $515K | $810K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $235K | $413K | $524K | $490K | $143K | $873K | $25K |
| Total Long-Term Assets | $11.49M | $13.31M | $14.93M | $16.39M | $746K | $1.39M | $835K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $105.56M | $94.65M | $107.65M | $114.11M | $133.56M | $55.95M | $21.09M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $2.22M | $2.95M | $2.33M | $2.15M | $1.38M | $949K | $903K |
| Short-Term Debt | $2.12M | $0 | $0 | $0 | $0 | $2.04M | $62.8M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $141K | $555K | $1.09M | $0 | $0 | $0 | $6.73M |
| Other Current Liabilities | $2.85M | $0 | $0 | $0 | $490K | $666K | $1.01M |
| Total Current Liabilities | $17.81M | $15.16M | $16.23M | $10.98M | $9.3M | $9.6M | $75.15M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $58.88M | $59.52M | $56.95M | $52.91M | $49.85M | $50.82M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $911K | $143.37M | $75.3M |
| Total Long-Term Liabilities | $68.72M | $71.48M | $70.77M | $68.35M | $50.76M | $194.19M | $75.3M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $86.53M | $86.63M | $87M | $79.33M | $60.06M | $203.78M | $150.44M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $73.57M |
| Common Stock | $34K | $30K | $28K | $25K | $24K | $0 | $1K |
| Retained Earnings | -$552.41M | -$530.95M | -$503.81M | -$470.85M | -$423.77M | -$387.69M | -$363.64M |
| Comprehensive Income & Other | $0 | $0 | $0 | -$1.11M | -$272K | $33K | $1K |
| Other Stockholders' Equity | $571.41M | $538.93M | $524.43M | $505.61M | $497.25M | $239.86M | $234.29M |
| Total Equity | $19.03M | $8.01M | $20.65M | $34.78M | $73.5M | -$147.83M | -$129.35M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $105.56M | $94.65M | $107.65M | $114.11M | $133.56M | $55.95M | $21.09M |
| Supplementary Data | |||||||
| Total Debt | $70.84M | $73.34M | $72.39M | $69.77M | $49.85M | $52.86M | $62.8M |
| Net Debt | $49.15M | $59.91M | $54.34M | $63.16M | $30.66M | $26.47M | $58.68M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$21.46M | -$27.14M | -$32.96M | -$47.08M | -$36.08M | -$24.28M | -$29.97M |
| Depreciation & Amortization | $1.95M | $1.77M | $1.6M | $2.99M | $296K | $312K | $421K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $5.48M | $0 | $0 |
| Stock-Based Compensation | $11.09M | $10.28M | $9.56M | $8.35M | $4.29M | $1.38M | $1.44M |
| Changes in Working Capital: | |||||||
| Accounts Receivable | -$1.83M | -$537K | -$4.85M | -$391K | $1.3M | -$2.38M | -$750K |
| Inventory | -$3.67M | $251K | -$1.7M | -$2.13M | -$1.16M | $672K | -$1.64M |
| Accounts Payable | -$730K | $671K | $240K | $647K | $479K | -$5K | -$82K |
| Other Working Capital | $2.22M | -$5.84M | $3.82M | -$2.91M | -$259K | -$356K | $2.48M |
| Total Working Capital Change | -$4.01M | -$5.45M | -$2.48M | -$4.79M | $368K | -$2.07M | $9K |
| Other Non-Cash Items | $1.43M | $2.59M | $4.58M | $3.67M | $1.07M | $3.04M | $3.08M |
| Net Cash from Operating | -$11.01M | -$17.95M | -$19.7M | -$36.87M | -$24.58M | -$21.61M | -$25.03M |
| Investing Activities | |||||||
| Capital Expenditures | -$332K | -$306K | -$173K | -$603K | -$384K | -$62K | -$468K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$85.01M | -$17M | -$18.02M |
| Sales of Investments | $0 | $9.3M | $23.2M | $24.4M | $0 | $6.3M | $22.1M |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $4K |
| Net Cash from Investing | -$332K | $8.99M | $23.03M | $23.8M | -$85.4M | -$10.77M | $3.62M |
| Financing Activities | |||||||
| Debt Repaid | $2.07M | - | - | - | $4.09M | -$24.46M | -$21.33M |
| Common Stock Issuance | $71.76M | $3.28M | $7.89M | $0 | $109.09M | $0 | $0 |
| Common Stock Repurchases | -$49.55M | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$543K | $1.05M | $239K | $490K | -$2.47M | -$1.15M | $42K |
| Net Cash from Financing | $19.6M | $4.33M | $8.13M | $490K | $102.53M | $55.01M | $21.37M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $8.26M | -$4.63M | $11.45M | -$12.58M | -$7.45M | $22.63M | -$38K |
| Supplementary Data | |||||||
| Operating Cash Flow | -$11.01M | -$17.95M | -$19.7M | -$36.87M | -$24.58M | -$21.61M | -$25.03M |
| Capital Expenditure | -$332K | -$306K | -$173K | -$603K | -$384K | -$62K | -$468K |
| Free Cash Flow | -$11.34M | -$18.25M | -$19.87M | -$37.47M | -$24.96M | -$21.67M | -$25.49M |
| Cash at Beginning | $13.55M | $18.18M | $6.73M | $19.31M | $26.76M | $4.12M | $4.16M |
| Cash at End | $21.81M | $13.55M | $18.18M | $6.73M | $19.31M | $26.76M | $4.12M |